METTL3-m6A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease

N6-methyladenosine (m6A) mRNA modification plays critical roles in various biological events and is involved in multiple complex diseases. However, the role of m6A modification in autophagy in nonalcoholic fatty liver disease (NAFLD) remains largely unknown. Here, we report that m6A modification was...

Full description

Saved in:
Bibliographic Details
Published inMolecular therapy Vol. 30; no. 2; pp. 932 - 946
Main Authors Peng, Zishan, Gong, Yingying, Wang, Xuejie, He, Weiman, Wu, Liting, Zhang, Luyao, Xiong, Li, Huang, Yanrui, Su, Lei, Shi, Peijie, Cao, Xiaopei, Liu, Rengyun, Li, Yanbing, Xiao, Haipeng
Format Journal Article
LanguageEnglish
Published Elsevier Inc 02.02.2022
American Society of Gene & Cell Therapy
Subjects
Online AccessGet full text

Cover

Loading…